Cancer stem cells and tumor angiogenesis

Area of Science:

• Oncology
• Cancer Biology
• Cellular Therapeutics

Background:

• Cancer stem cells (CSCs) are implicated in tumor initiation, metastasis, and therapeutic resistance across various human cancers.
• CSCs possess distinct cell surface markers and contribute to treatment failure by resisting chemotherapy and radiation.
• Their inherent resistance is linked to elevated expression of antiapoptotic proteins.

Purpose of the Study:

• To investigate the role of cancer stem cells in tumor formation and metastasis.
• To understand the mechanisms underlying CSC resistance to conventional cancer therapies.
• To explore the potential of targeting CSCs as a novel cancer prevention strategy.

Main Methods:

• Identification and characterization of CSCs in human solid and hematological tumors.
• Analysis of CSC-specific cell surface markers.
• Assessment of CSC resistance mechanisms, including antiapoptotic protein expression.
• Evaluation of CSC-targeting agents in preclinical models (implied).

Main Results:

• CSCs were identified as key drivers of tumor initiation and metastasis.
• CSCs exhibit significant resistance to chemotherapy and radiation therapy compared to non-CSCs.
• Increased expression of antiapoptotic proteins contributes to CSC survival and treatment resistance.

Conclusions:

• Eliminating or controlling cancer stem cells is a critical therapeutic goal.
• Targeting CSCs represents a viable and effective strategy for cancer prevention.
• Further development of CSC-specific agents is warranted to improve cancer treatment outcomes.